Lyme and Co-Infection Nosode

Lyme and Co-Infection Nosode is an FDA-registered drug product whose active ingredient is ANGELICA ARCHANGELICA, KALI MURIATICUM, YUCCA FILAMENTOSA, CARTILAGO SUIS, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, RHUS TOX, CAUSTICUM, MAGNESIA PHOSPHORICA, MANGANUM METALLICUM, OXALICUM ACIDUM, ARNICA MONTANA, BABESIA MICROTI, BORRELIA BURGDORFERI NOSODE, LATRODECTUS MACTANS, CITRICUM ACIDUM, CYTOMEGALOVIRUS NOSODE, RICKETTSIA NOSODE (RICKETTSIA PROWAZEKII), CHLAMYDIA TRACHOMATIS, LEDUM PALUSTRE. It is labelled by Bhp Holdings, Inc. taken by oral and marketed as a human otc drug product. Identifiers on file: NDC 58048-0005, label effective 20230601. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

Across FDA labelling, products containing ANGELICA ARCHANGELICA, KALI MURIATICUM, YUCCA FILAMENTOSA, CARTILAGO SUIS, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, RHUS TOX, CAUSTICUM, MAGNESIA PHOSPHORICA, MANGANUM METALLICUM, OXALICUM ACIDUM, ARNICA MONTANA, BABESIA MICROTI, BORRELIA BURGDORFERI NOSODE, LATRODECTUS MACTANS, CITRICUM ACIDUM, CYTOMEGALOVIRUS NOSODE, RICKETTSIA NOSODE (RICKETTSIA PROWAZEKII), CHLAMYDIA TRACHOMATIS, LEDUM PALUSTRE are most often described in connection with: indications supports, immune system, host resistance, lyme disease. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

INDICATIONS: Supports the immune system for host resistance to Lyme disease and co-infections.

DIRECTIONS: Take 10 drops 1 to 3 times per day under the tongue 30 minutes before meal or as directed by a Health Care Practitioner. Consult your physician for use in children under 12 years of age.

WARNINGS: If pregnant or nursing ask your health Care Practitioner before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry and dark place.

What is Lyme and Co-Infection Nosode used for?
INDICATIONS: Supports the immune system for host resistance to Lyme disease and co-infections.

Who makes Lyme and Co-Infection Nosode?
Bhp Holdings, Inc. is the labeler of record for Lyme and Co-Infection Nosode.

What form does Lyme and Co-Infection Nosode come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is Lyme and Co-Infection Nosode prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Has Lyme and Co-Infection Nosode been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.